Title : Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors.

Pub. Date : 2021 Oct 26

PMID : 34698927






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As most cases of FH are attributable to mutations in the gene encoding the low-density lipoprotein receptor (LDLR), statins, even in combination with ezetimibe, are less effective in reducing LDL-C plasma levels in FH patients, who require a more intensive approach with additional lipid-lowering agents. Ezetimibe low density lipoprotein receptor Homo sapiens